206 related articles for article (PubMed ID: 32210734)
1. The role of WT1 in breast cancer: clinical implications, biological effects and molecular mechanism.
Zhang Y; Yan WT; Yang ZY; Li YL; Tan XN; Jiang J; Zhang Y; Qi XW
Int J Biol Sci; 2020; 16(8):1474-1480. PubMed ID: 32210734
[TBL] [Abstract][Full Text] [Related]
2. Correlation of Wilms' tumor 1 isoforms with HER2 and ER-α and its oncogenic role in breast cancer.
Nasomyon T; Samphao S; Sangkhathat S; Mahattanobon S; Graidist P
Anticancer Res; 2014 Mar; 34(3):1333-42. PubMed ID: 24596380
[TBL] [Abstract][Full Text] [Related]
3. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells.
Han Y; San-Marina S; Yang L; Khoury H; Minden MD
Breast Cancer Res; 2007; 9(4):R43. PubMed ID: 17634147
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-193a inhibits breast cancer proliferation and metastasis by downregulating WT1.
Xie F; Hosany S; Zhong S; Jiang Y; Zhang F; Lin L; Wang X; Gao S; Hu X
PLoS One; 2017; 12(10):e0185565. PubMed ID: 29016617
[TBL] [Abstract][Full Text] [Related]
5. The WT1 Wilms' tumor suppressor gene product interacts with estrogen receptor-alpha and regulates IGF-I receptor gene transcription in breast cancer cells.
Reizner N; Maor S; Sarfstein R; Abramovitch S; Welshons WV; Curran EM; Lee AV; Werner H
J Mol Endocrinol; 2005 Aug; 35(1):135-44. PubMed ID: 16087727
[TBL] [Abstract][Full Text] [Related]
6. The Wilms' tumor suppressor WT1 induces estrogen-independent growth and anti-estrogen insensitivity in ER-positive breast cancer MCF7 cells.
Wang L; Wang ZY
Oncol Rep; 2010 Apr; 23(4):1109-17. PubMed ID: 20204298
[TBL] [Abstract][Full Text] [Related]
7. Wilms' tumor 1 suppressor gene mediates antiestrogen resistance via down-regulation of estrogen receptor-alpha expression in breast cancer cells.
Han Y; Yang L; Suarez-Saiz F; San-Marina S; Cui J; Minden MD
Mol Cancer Res; 2008 Aug; 6(8):1347-55. PubMed ID: 18708366
[TBL] [Abstract][Full Text] [Related]
8. The Wilms' tumor suppressor WT1 inhibits malignant progression of neoplastigenic mammary epithelial cells.
Wang L; Wang ZY
Anticancer Res; 2008; 28(4B):2155-60. PubMed ID: 18751389
[TBL] [Abstract][Full Text] [Related]
9. WT1 expression in breast cancer disrupts the epithelial/mesenchymal balance of tumour cells and correlates with the metabolic response to docetaxel.
Artibani M; Sims AH; Slight J; Aitken S; Thornburn A; Muir M; Brunton VG; Del-Pozo J; Morrison LR; Katz E; Hastie ND; Hohenstein P
Sci Rep; 2017 Mar; 7():45255. PubMed ID: 28345629
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of breast cancer cell growth by the Wilms' tumor suppressor WT1 is associated with a destabilization of beta-catenin.
Zhang TF; Yu SQ; Guan LS; Wang ZY
Anticancer Res; 2003; 23(5A):3575-84. PubMed ID: 14666652
[TBL] [Abstract][Full Text] [Related]
11. [Promoter methylation and mRNA expression of WT1 gene in MCF10 breast cancer model].
Yang JL; Klinkebiel D; Boland MJ; Tang L; Christman JK
Zhonghua Bing Li Xue Za Zhi; 2007 Apr; 36(4):253-8. PubMed ID: 17706117
[TBL] [Abstract][Full Text] [Related]
12. High expression of Wilms' tumor suppressor gene predicts poor prognosis in breast cancer patients.
Miyoshi Y; Ando A; Egawa C; Taguchi T; Tamaki Y; Tamaki H; Sugiyama H; Noguchi S
Clin Cancer Res; 2002 May; 8(5):1167-71. PubMed ID: 12006533
[TBL] [Abstract][Full Text] [Related]
13. Wilms' tumor protein 1: an early target of progestin regulation in T-47D breast cancer cells that modulates proliferation and differentiation.
Caldon CE; Lee CS; Sutherland RL; Musgrove EA
Oncogene; 2008 Jan; 27(1):126-38. PubMed ID: 17599043
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional regulation of the human thromboxane A2 receptor gene by Wilms' tumor (WT)1 and hypermethylated in cancer (HIC) 1 in prostate and breast cancers.
Keating GL; Reid HM; Eivers SB; Mulvaney EP; Kinsella BT
Biochim Biophys Acta; 2014 Jun; 1839(6):476-92. PubMed ID: 24747176
[TBL] [Abstract][Full Text] [Related]
15. Absence of mutations in the Wilms' tumor gene WT1 in primary breast cancer.
Oji Y; Miyoshi Y; Kiyotoh E; Koga S; Nakano Y; Ando A; Hosen N; Tsuboi A; Kawakami M; Ikegame K; Oka Y; Ogawa H; Noguchi S; Sugiyama H
Jpn J Clin Oncol; 2004 Feb; 34(2):74-7. PubMed ID: 15067099
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor I regulates the expression of isoforms of Wilms' tumor 1 gene in breast cancer.
Tuna M; Itamochi H
Tumori; 2013; 99(6):715-22. PubMed ID: 24503796
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of WT1 in all molecular subtypes of breast cancer and its impact on survival: exploring oncogenic and tumor suppressor roles of distinct WT1 isoforms.
Ben Haj Othmen H; Othman H; Khamessi O; Bettaieb I; Gara S; Kharrat M
Mol Biol Rep; 2024 Apr; 51(1):544. PubMed ID: 38642153
[TBL] [Abstract][Full Text] [Related]
18. Novel WT1 Target Genes:
Dejjuy D; Dechsukhum C; Pattanapanyasat K; Noulsri E; Dissen GA; Leeanansaksiri W
Biomed Res Int; 2020; 2020():7851414. PubMed ID: 33110919
[TBL] [Abstract][Full Text] [Related]
19. HER2/neu increases the expression of Wilms' Tumor 1 (WT1) protein to stimulate S-phase proliferation and inhibit apoptosis in breast cancer cells.
Tuna M; Chavez-Reyes A; Tari AM
Oncogene; 2005 Feb; 24(9):1648-52. PubMed ID: 15674342
[TBL] [Abstract][Full Text] [Related]
20. The Wilms' tumor suppressor WT1 is associated with melanoma proliferation.
Wagner N; Panelos J; Massi D; Wagner KD
Pflugers Arch; 2008 Feb; 455(5):839-47. PubMed ID: 17912546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
